Quaker Chemical Corporation (KWR) saw its stock price plummet by 6.24% in pre-market trading on Friday, following the release of its first-quarter earnings report for 2025. Despite slightly beating analyst expectations on earnings per share, the company reported a significant decline in revenue, prompting investor concern.

According to the earnings summary, Quaker Chemical reported adjusted earnings of $1.58 per share for the quarter ended March 31, narrowly surpassing the mean analyst expectation of $1.57. However, this figure represents a substantial decrease from the $2.09 per share reported in the same quarter last year. More alarmingly, the company's revenue fell by 5.7% to $442.91 million, falling short of the $454.80 million anticipated by analysts. The reported net income for the quarter stood at $12.92 million, with a reported EPS of 73 cents.

The disappointing results appear to have exacerbated Quaker Chemical's already challenging year, with shares having fallen by 14.3% this quarter and 24.7% year-to-date. Despite these setbacks, the current average analyst rating on the shares remains a "buy," with a median 12-month price target of $142.50. However, it's worth noting that the mean earnings estimate has fallen by about 18.2% in the last three months, with three analysts negatively revising their earnings estimates in the past 30 days, suggesting growing caution about the company's near-term prospects.